Ampersand buys Peptides International, merges it with New England Peptide
Ampersand Capital Partners has acquired Peptides International and merged it with portfolio company New England Peptide.
16 December 2019•3 mins read
Ampersand Capital Partners has acquired Peptides International and merged it with portfolio company New England Peptide.
Paradigm Equity Partners acquires upholstery and performance fabric maker STI Fabrics
12 hours ago · 1 min read
KKR and Hildred merge diagnostics businesses Sapphiros and binx health into Onvaro
12 hours ago · 2 mins read
Eir Partners-backed Porter acquires health plan analytics firm Pareto Intelligence
13 hours ago · 1 min read
Bain Capital’s LeanTaaS snaps up hospital care transition platform Aidin
13 hours ago · 2 mins read
Carlyle-backed Vantive agrees hemodialysis business sale to Rockwell Medical
13 hours ago · 2 mins read
Novacap completes OSI Maritime Systems acquisition as first Fund VII deal
13 hours ago · 2 mins read
Long Arc-backed Robertson Stephens adds Denver adviser Altius Financial
13 hours ago · 1 min read
